Can I read Therapeutic Potential of Tolerance-based Peptide Vaccines in Autoimmune Diseases on EtoBox?

Therapeutic Potential of Tolerance-based Peptide Vaccines in Autoimmune Diseases by Xueting Yu; Yaping Mai; Yaya Wei; Na Yu; Ting Gao; Jianhong Yang is a Immunology and Microbiology article available to read on EtoBox.

What is Therapeutic Potential of Tolerance-based Peptide Vaccines in Autoimmune Diseases about?

Autoimmune diseases are caused by the dysfunction of the body’s immune regulatory system, which leads to the recognition of self-antigens and the destruction of self-tissues and is mediated by immune cells such as T and B cells, and affects 5–10% of the population worldwide. Current treatments such as non-steroidal anti-inflammatory drugs and glucocorticoids can only relieve symptoms of the disease and are accompanied by serious side effects that affect patient quality of life. The recent rise in antigen-specific therapies, especially vaccines carrying autoantigenic peptides, promises to change this disadvantage, where research has increased dramatically in the last decade. This therapy established specific immune tolerance by delivering peptide fragments containing disease-specific self-antigen epitopes to suppress excessive immune responses, thereby exerting a therapeutic effect, with high safety and specificity. This article presents the latest progress on the treatment of autoimmune diseases with autoantigen peptide vaccines. It includes the construction of peptide vaccine delivery system, the mechanism of inducing immune tolerance and its application.

Who reads Therapeutic Potential of Tolerance-based Peptide Vaccines in Autoimmune Diseases?

Author

Xueting Yu; Yaping Mai; Yaya Wei; Na Yu; Ting Gao; Jianhong Yang

Publisher

Elsevier BV

Published

2023

Language

EN

Field

Immunology and Microbiology (Life Sciences)